Ps-1Pb

General Information


DRACP ID  DRACP00516

Peptide Name   Ps-1Pb

Sequence  IKIPSFFRNILKKVGKEAVSLIAGALKQS

Sequence Length  29

UniProt ID  Not available

PubChem CID  Not available

Origin  skin secretions of the frog Pseudhymenochirus merlini (Pipidae)

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma LC50=2.5±0.2 μM CellTiter-Glo Luminescent Cell Viability assay 24h 1
MDA-MB-231 Breast adenocarcinoma Carcinoma LC50=6.6±0.3 μM CellTiter-Glo Luminescent Cell Viability assay 24h 1
HT-29 Colon adenocarcinoma Carcinoma LC50=9.5±1.3 μM CellTiter-Glo Luminescent Cell Viability assay 24h 1

Hemolytic Activity  Human red blood cells (RBC): LC50>403 μM

Normal (non-cancerous) Cytotoxicity  HUVEC: LC50=5.6±0.9 μM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00516

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C147H251N39O37

Absent amino acids  CDHMTWY

Common amino acids  K

Mass  365647

Pl  11.37

Basic residues  6

Acidic residues  1

Hydrophobic residues  14

Net charge  5

Boman Index  -1607

Hydrophobicity  32.76

Aliphatic Index  124.48

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 25447194

Title  Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa

Doi 10.1016/j.regpep.2014.11.001

Year  2014

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.